GI
WST icon

Gradient Investments’s West Pharmaceutical WST Stock Holding History

Gradient Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$2.82K – 1858
2023
Q4 		$2.82K Hold
8
– – ﹤0.01% 1142
2023
Q3 		$3K Buy
8
+4
+100% +$1.55K ﹤0.01% 1072
2023
Q2 		$1.53K Buy
4
+3
+300% +$1.07K ﹤0.01% 1225
2023
Q1 		$346 Hold
1
– – ﹤0.01% 1319
2022
Q4 		$235 Sell
1
-25
-96% -$5.92K ﹤0.01% 1369
2022
Q3 		$6K Buy
+26
New +$7.92K ﹤0.01% 934
2019
Q4 		– Sell
-36
Closed -$5K – 1250
2019
Q3 		$5K Buy
+36
New +$4.96K ﹤0.01% 810
2019
Q1 		– Sell
-66
Closed -$6K – 1018
2018
Q4 		$6K Buy
+66
New +$7.16K ﹤0.01% 690

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return